Status:
COMPLETED
Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer
Lead Sponsor:
University Hospital, Ghent
Conditions:
Breast Cancer
Radiotherapy
Eligibility:
FEMALE
70+ years
Phase:
NA
Brief Summary
Adjuvant radiotherapy in breast cancer improves local control, also in the elderly. Hormonal therapy in hormone sensitive tumors improves results but can not substitute radiotherapy. Improved local co...
Detailed Description
Adjuvant radiotherapy in breast cancer improves local control and overall survival, also in the elderly. Hormonal therapy in hormone sensitive tumors improves results but can not substitute radiothera...
Eligibility Criteria
Inclusion
- ≥ 70 years old
- AND breast conserving surgery or mastectomy for breast carcinoma
- AND multidisciplinary decision of adjuvant irradiation
- AND absence of distant metastases
- AND informed consent obtained, signed and dated before specific protocol procedures
Exclusion
- Bilateral breast irradiation
- In case of mastectomy: positive resection margin, needing boost
- Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
- Patient unlikely to comply with the protocol; i.e. uncooperative attitude, inability to return for follow-up visits, and unlikely to complete the study
- History of previous radiation treatment to the same region
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 13 2018
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04098926
Start Date
January 1 2015
End Date
July 13 2018
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital - Radiotherapy Department
Ghent, Belgium, 9000